Stock Analysis of NewAmsterdam Pharma Co. WT (NAMSW) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code NAMSW
Close 9.39
Change -0.110 / 1.16 %
Volume 1982.00
Vol Change 59.00 / 3.07 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthNeutral
Growth Index Poor Growth Stock
Value Index Poor Value Stock
Profitability Index Poor Profitability Stock
Stability Index No Significant Stability


Fundamental View of NewAmsterdam Pharma Co. WT
PE (TTM)

-4.40

Very Poor
Price / Book

1.84

Indecisive
Price / Sales

65.40

Very Poor
Piotroski F Score

1.0

Very Poor
Market Cap

0

Enterprise Value

0

ROA (TTM)

-37.00

Very Poor
ROE (TTM)

-41.93

Very Poor
Net Margin (TTM)

-1487.25

Very Poor
Revenue

85.55 %

14090.00 K
Net Profit

126.69 %

-176937.00 K
Debt to Equity

0.0002

Excellent
Altman Z Score

-1.95

Very Poor
Quick Ratio

6.99

Excellent
Cash Ratio

6.82

Excellent


Highs/Lows of NewAmsterdam Pharma Co. WT
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week10.325 9.06 % 1.54 % 10.09.017-May-2415-May-24
Two Week10.96 14.32 % 3.42 % 11.59.006-May-2415-May-24
One Month9.61 2.29 % 5.60 % 11.59.006-May-2415-May-24
Three Month9.5 1.16 % 5.95 % 14.247.584729-Feb-2427-Feb-24
Six Months2.1502 336.70 % 17.48 % 14.671.710125-Jan-2421-Nov-23
One year1.1 753.64 % 27.52 % 14.671.0225-Jan-2419-May-23
Two year0.119 7790.76 % 29.70 % 14.670.0925-Jan-2419-Jul-22


Technical View of NewAmsterdam Pharma Co. WT
RSI

45.62

Neutral
MACD

-0.209

Mild Bearish
ADX

15.00

Bullish
Super Trend

11.31

Mild Bearish
Williams %R

-84.40

Mild Bullish
CCI

-46.10

Neutral


EMA 5

9.53

Mild Bearish
EMA 15

9.82

Strong Bearish
EMA 50

9.74

Mild Bearish
EMA 100

8.38

Bullish
SMA 100

8.28

Bullish
SMA 200

5.08

Bullish
SMA 5 / 20

9.54 / 9.88

Mild Bearish
SMA 15 / 50

9.82 / 10.49

Mild Bearish
SMA 50 / 200

10.49 / 5.08

Strong Bullish




Charts of NewAmsterdam Pharma Co. WT


Returns of NewAmsterdam Pharma Co. WT with Peers
Period / StockNAMSWQSAMUTRS
1 Week-9.06%2.60%0%
1 Mth-2.29%12.16%-99.82%
3 Mth-1.16%55.14%-99.88%
6mth336.70%59.62%-99.97%
1 Year753.64%38.91%-99.98%
2 Year7790.76%43.10%-100.00%
5 Years-2113.33%-
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of NewAmsterdam Pharma Co. WT with Peers
Ratio / StockNAMSWQSAMUTRS
PE-4.40-5.01-0.0232
P/B1.84-49.990.051
ROA-37.00-576.91-66.79
ROE-41.930-217.71
Debt To Equity0.00020.04600
Revenue14090.00 K
85.55 % 		0
% 		51693.00 K
2.78 %
Net Income-176937.00 K
126.69 % 		-5085.07 K
16.29 % 		-33450.00 K
1.94 %


Technicals of NewAmsterdam Pharma Co. WT with Peers
Technical / StockNAMSWQSAMUTRS-
ADX15.0024.4335.70
CMF-0.1640.4950.0444
MFI36.0566.662.82
RSI45.6268.6930.41
MACD Abv SignalFalseFalseFalse
Price Above 50 MAFalseTrueFalse-
Price Above 200 MATrueTrueFalse-


About : NewAmsterdam Pharma Company N.V. Warrant

Address : Gooimeer 2-35, Naarden, Netherlands, 1411 DC
Tel : 31 35 206 2971
URL : https://www.newamsterdampharma.com
Code : NAMSW, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 23_Nov_2022
Employee Count : 29

NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with metabolic disease. It is developing obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases. The company also develops Obicetrapib which is in Phase 2a clinical trial for Alzheimer's disease. NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands.


Note : All Data Generated at the End of Trading Hours (EOD Data)